Approved Study Database

Ref. No. Scientific Title Principal investigator
2019.442 Twelve-Year Review on The Screening of Glycosuria in Obese School Children and Adolescents for Early Diagnosis of Type 2 Diabetes Mellitus, A Retrospective Study in Hong Kong Dr YAU Ho Chung
2019.443 L-asparaginase Associated Acute Pancreatitis in Children with Acute Lymphoblastic Leukemia Dr. WU Huijin
巫慧鈞
2019.444 Characterization of fibrotic focus as a prognostic marker in breast cancer Dr. TSE Gary
謝文杰
2019.445 Tumor immune microenvironment (TIME) to predict treatment response in breast cancer Dr. NI Yunbi
倪韵碧
2019.446 Generation of host genetic factor information known to associate with hospitalized severe influenza Dr. CHAN Chi Wai
陳子蔚
2019.447 Discontinuation of drug treatment for attention deficit hyperactivity disorder among children and adolescents in a community hospital in Hong Kong Dr. LIU Ka Yee
劉嘉儀
2019.448 Progression of symptomatic intracranial atherosclerotic disease: an interplay between plaque morphology and fluid dynamics Dr. LENG Xinyi
2019.449 Multicenter Randomized Controlled Trial of Gastric Endoscopic Submucosal Dissection with or without Epinephrine Added Solution Dr. YIP Hon Chi
2019.451 A 24-week multi-center, double-blind, placebo controlled dose-range finding study to investigate the efficacy and safety of oral QBW251 in COPD patients on triple inhaled therapy (LABA/LAMA/ICS) Prof. HUI David Shu Cheong
許樹昌
2019.452 Ventricle from Atrium Heart Failure (VFAHF) Clinical Study Dr. CHAN Joseph Yat Sun
陳日新
2019.453 An open-label, multi-center, Phase IV, roll-over study in patients with ALK positive malignancies who have completed a prior Novartis-sponsored ceritinib (LDK378) study and are judged by the investigator to benefit from continued treatment with ceritinib Dr. LOONG Herbert Ho Fung
龍浩鋒醫生
2019.454 A Randomized, Open-Label, International, Multi-Center, Phase 3 Clinical Study of PD-1 Antibody SHR-1210 Plus Apatinib (Rivoceranib) Mesylate Versus Sorafenib as First-Line Therapy in Subjects with Advanced Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Therapy Dr. CHAN Stephen Lam
陳林
2019.455 Evaluation of a Frailty Intervention Program in Hong Kong: A Pre-Post Study and a Focus Group Study Prof. WOO Jean
2019.456 Determining the Effects of Superfine Sheep Wool Clothing for Atopic Dermatitis: A Multicentre, Randomized, Paediatric, Crossover study Dr. CHOW Chung Mo
周中武
2019.457 A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201) Dr. LOONG Herbert Ho Fung
龍浩鋒
2019.458 A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advanced Hepatocellular Carcinoma Dr. CHAN Stephen Lam
陳林
2019.459 Family Risk Factors of Dyslexia in Chinese: Evidence at Behavioral, Neurological and Genetic Levels Prof. MAURER Urs
2019.460 Effectiveness of an education and support intervention for family members of nursing home residents with dementia: A sequential embedded mixed methods study Miss HUI Zhaozhao
惠沼沼
2019.461 Development, Validation and Psychometric Evaluation of the Chinese version of the Frontotemporal Dementia Rating Scale (C-FTD-FRS) Dr. KO Shuk Fun
2019.462 The association of glycemic control and fall risk in diabetic elderly in a general outpatient clinic Dr CHENG Long Yee
鄭朗兒
2019.463 Retrospective study comparing laparoscopic placement of peritoneal dialysis catheter plus omentectomy and closure of patent processus vaginalis versus open catheter placement in children Dr. TAM Yuk Him
2019.464 Retrospective study of mitochondrial disorders in Hong Kong Dr. CHONG Shuk Ching
莊淑貞
2019.465 Ultrasound Findings of Vertebral Artery Flow Asymmetry Dr. SO Tiffany Y.
2019.466 Datasets for Genetic Analysis of Cardiovascular and Related Diseases Dr. TEEKAKIRIKUL Polakit
2019.468 The prevalence of chromosomal abnormalities in fetuses with different degree of cerebral ventriculomegaly and the association of neurodevelopmental outcome after birth Dr. LOK Wing Yi
2019.469 Promoting physical activity and fundamental movement skills in preschool-aged children through family-based intervention: a randomized controlled trial Miss HE Qing
何青
2019.470 An investigation on the trend and risk factors of dysphagia in elderly in residential care homes for the elderly (RCHEs) Mr. FONG Raymond
方思行
2019.471 A Multilevel Implementation Study for Physical Activity Promotion in Children with Disabilities Prof. SIT Cindy Hui Ping
薛慧萍
2019.473 Visceral, subcutaneous, ectopic and brown fat in lean and obese people living with HIV with and without non-alcoholic fatty liver disease Prof. LUI Grace Chung Yan
雷頌恩
2019.474 A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF ATEZOLIZUMAB (ANTI-PD-L1 ANTIBODY) PLUS BEVACIZUMAB VERSUS ACTIVE SURVEILLANCE AS ADJUVANT THERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AT HIGH RISK OF RECURRENCE AFTER SURGICAL RESECTION OR ABLATION Prof. CHAN Stephen Lam
陳林 醫生
2019.475 Frailty in daily practice: screening, consultation and education activities Prof. WOO Jean
=
2019.476 A PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF IPATASERTIB IN COMBINATION WITH ATEZOLIZUMAB AND PACLITAXEL AS A TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER Prof. YEO Winnie
楊明明 教授
2019.477 A Multicenter, Open-label, Single-arm, Phase Ib Dose Escalation and Multi-cohort Expansion Clinical Study to Assess the Safety and Antitumor Activity of Niraparib in Combination with MGD013 in Patients with Advanced or Metastatic Solid Tumor Who Failed Prior Treatment Dr. LOONG Herbert Ho-fung
2019.478 Glaucoma demographics and treatment outcomes in Hong Kong Prof. THAM Clement Chee Yung
譚智勇
2019.480 Development of decision support tools for sepsis management and prevention of acute kidney injury in Intensive Care using machine learning techniques: a feasibility study Prof. LING Lowell
2019.481 AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF REGN3918 IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA Dr. WONG Raymond Siu Ming
2019.482 Modulations of gut microbiota and metabolites by dietary intervention with heat-stabilised rice bran in adults of high risk colorectal cancer - a double blinded randomized controlled study Dr. SO Winnie K.W.
蘇幗慧
2019.483 Comparison of Arthroscopic Debridement and Arthroscopic Hemi-Trapeziectomy with Mini TightRope on Patients with Thumb Carpometacarpal Joint Osteoarthritis - A Prospective Randomized Single-Blinded Controlled Trial Dr. MAK Michael Chu Kay
麥柱基
2019.484 Validation of Preeclampsia Detection kit (Point-of-Care test) Prof. POON Liona Chiu Yee
潘昭頤
2019.485 Clinical Effectiveness of Hypertonic Dextrose Prolotherapy in Chronic Ankle Instability: A Randomized Clinical Trial Prof. SIT Wing Shan
薛詠珊
2019.486 Effectiveness of a nurse-led medication self-management intervention for improving medication adherence in community-dwelling older patients with multimorbidity: A randomized controlled trial Mr. YANG Chen
杨琛
2019.487 Self-management Behaviours and Disease Control of Type 2 Diabetes Mellitus Patients Among Working Population in Hong Kong Ms. HUNG Heidi
洪凱兒
2019.488 The effect of whole body vibration therapy on increasing quadriceps strength prior to anterior cruciate ligament reconstruction Prof. ONG Tim Yun
王添欣
2019.489 Multiparametric MRI-based radiological activity score (RAS) in Thyroid Associated Orbitopathy (TAO) Dr. CHONG Kelvin Kam Lung
莊金隆
2019.490 HybridAPC for the Treatment of Gastric Low Grade Intraepithelial Neoplasia (LGIN)---- a Prospective, Multi-center Study Prof. CHIU Philip Wai Yan
趙偉仁
2019.491 Patient Preference of Apalutamide versus Enzalutamide in Patients with Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial. (version 1.0) Prof. NG Chi Fai
吳志輝
2019.492 A study on the view of Hong Kong parents on secondary use of dried blood spots in newborn screening program - implications on evidence-based policies Dr. HUI Lai Ling
許麗玲
2019.493 A Phase 1 Study of BOS172738 in Patients with Advanced Solid Tumors with RET Gene Alterations including Non-Small Cell Lung Cancer (NSCLC) and Medullary Thyroid Cancer (MTC) Dr. LOONG Herbert Ho Fung
2019.494 The establishment of airway ciliary motion assessment platform Prof. CHAN Wan Yi
陳韻怡
2019.495 Exploring the Impact of Maxillary Osteotomy on Speech Articulation in Cleft and Non-Cleft Lip & Palate: An Acoustic Analysis and Cross-Linguistic Comparison Dr. PEREIRA Valerie
NA

Page 187 of 254.